| Literature DB >> 20179756 |
Young-Beob Yu1, Laura Dosanjh, Lixing Lao, Ming Tan, Bum Sang Shim, Yuan Luo.
Abstract
BACKGROUND: Proving the efficacy and corresponding mode of action of herbal supplements is a difficult challenge for evidence-based herbal therapy. A major hurdle is the complexity of herbal preparations, many of which combine multiple herbs, particularly when the combination is assumed to be vitally important to the effectiveness of the herbal therapy. This issue may be addressed through the use of contemporary methodology and validated animal models. METHODS AND PRINCIPALEntities:
Mesh:
Substances:
Year: 2010 PMID: 20179756 PMCID: PMC2825258 DOI: 10.1371/journal.pone.0009339
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Botanical names and origin of the formulas SQDB and HLXL.
| SQDB | HLXL |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Rehmannia glutinosa [root] [Rehmanniae Radix Preparata, Shudihuang] |
|
|
|
Description of C. elegans strains.
| Strain | Gene | Expression | Phenotype | Assay |
| N2 | Wild type | Life span | ||
|
| 5-HT receptor | Increased life span | Life span | |
|
| Insulin pathway | Decreased life span | Life span | |
|
| Electron transport | ROS sensitive | Life span | |
| CL4176 |
| Inducible muscle Aβ | Rapid paralysis | Paralysis |
| CL2070 | GFP reporter for sHSPs | GFP | Thermal, oxidative stress |
Life span assays in wild type C. elegans fed with SQDB and individual herbs.
| N2 strain | No. of experiments | Mean life span (days) | % change | No. of animal (+/−herbs) | p-value |
| Control | 4 | 19.9 | 322 | ||
| Mianserin | 4 | 27.1 | 35.9 | 315/322 | 0.0000 |
| SQDB | 3 | 22.3 | 11.7 | 233/322 |
|
|
| 2 | 20.0 | 0.2 | 65/322 | n.s. (0.8317) |
|
| 2 | 20.9 | 4.8 | 70/322 | n.s. (0.5422) |
|
| 2 | 19.7 | −1.1 | 53/322 | n.s. (0.6144) |
|
| 3 | 22.1 | 10.8 | 170/322 |
|
|
| 2 | 19.8 | −0.8 | 56/322 | n.s. (0.9064) |
|
| 2 | 20.7 | 3.6 | 62/322 | n.s. (0.9328) |
|
| 2 | 19.4 | −2.8 | 58/322 | n.s. (0.2946) |
|
| 3 | 21.5 | 7.7 | 167/322 |
|
|
| 2 | 19.8 | −0.9 | 72/322 | n.s. (0.3162) |
|
| 2 | 20.9 | 4.7 | 60/322 | n.s. (0.9481) |
*P<0.005, Statistical significant; n.s. P>0.005 not significant.
Life span assays in wild type C. elegans fed with HLXL and individual herbs.
| N2 strain | No. of experiments | Mean life span (days) | % change | No. of animals | p-value |
| Control | 3 | 19.5 | 141 | ||
| HLXL | 2 | 20.7 | 5.7 | 139 | n.s.(0.1364) |
|
| 1 | 21.0 | 7.5 | 35 | n.s.(0.1892) |
|
| 1 | 19.2 | −2.0 | 39 | n.s.(0.5373) |
|
| 1 | 17.0 | −13.0 | 29 | n.s.(0.4937) |
|
| 2 | 22.4 | 14.5 | 93 |
|
|
| 1 | 17.7 | −9.4 | 30 | n.s. (0.3039) |
|
| 1 | 20.2 | 3.2 | 35 | n.s.(0.2190) |
|
| 1 | 19.8 | 1.3 | 34 | n.s.(0.8503) |
|
| 1 | 19.2 | −1.7 | 20 | n.s.(0.3520) |
|
| 2 | 20.9 | 7.1 | 101 | n.s.(0.0744) |
|
| 1 | 19.4 | −0.9 | 39 | n.s.(0.8799) |
|
| 2 | 21.2 | 8.3 | 85 | n.s.(0.0539) |
*P<0.005, Statistical significant; n.s. P>0.005 not significant.
Figure 1Effect of Cinnamomum cassia (CIN) on life span in multiple pathway mutants of C. elegans.
Age synchronized control (circles) or CIN fed (triangles) worms were seeded in liquid medium at the L1 stage. CIN treatment began 68 h after seeding (day 1 of adult life) and the fraction of animals alive was scored microscopically on the basis of movement. A. CIN significantly extends life span in wild type worms but not in B. daf-16 C. mev-1 or D. ser-1 mutants. Survival rate was scored every day and is expressed as percentage of survival. The experiment was conducted at least three times with a minimum of 100 worms per trial. Statistical significant p<0.05, n.s. not significant.
Life span assays in mutant C. elegans fed with SQDB and individual herbs.
| Strains | Drugs | Mean life span (d) | % Change | No. of animal (+drug/−drug) | P-value |
| Control | 14 | 76 | |||
| SQDB | 15 | 7.1 | 57/76 | n.s. (0.295) | |
| HLXL | 15 | 7.1 | 64/76 | n.s. (0.8088) | |
|
|
| 15 | 7.1 | 85/76 | n.s. (0.0596) |
|
| 14 | 0.0 | 89/76 | n.s. (0.8369) | |
|
| 17 | 21.4 | 72/76 |
| |
| Control | 18 | 89 | |||
| SQDB | 22.4 | 24.4 | 100/89 |
| |
| HLXL | 17.6 | −2.2 | 100/89 | n.s. (0.3203) | |
|
|
| 19.8 | 10.0 | 88/89 | n.s. (0.1299) |
|
| 21.3 | 18.3 | 57/89 | n.s. (0.1054) | |
|
| 19.5 | 8.3 | 80/89 | n.s. (0.3296) | |
| Control | 13 | 85 | |||
| SQDB | 12 | −7.7 | 56/85 | n.s. (0.3368) | |
| HLXL | 13 | 0.0 | 66/85 | n.s. (0.4368) | |
|
|
| 13 | 0.0 | 63/85 | n.s. (0.3506) |
|
| 13 | 0.0 | 61/85 | n.s. (0.508) | |
|
| 14 | 7.7 | 69/85 | n.s. (0.416) |
*P<0.005, Statistical significant; n.s. P>0.005 not significant.
Summary.
| Assay | Strain | % Change (p value) | |||
| SQDB | GS | CIN | Statistics | ||
| Life span | N2 | 11.7 (0.0004) | 7.7(0.047) | 10.8(0.0017) | Log-rank test |
|
| 24.4(0.0045) | 8.3 (0.3296) | 10.0(0.1299) | ||
|
| 7.1(0.295) | 21.4(0.0006) | 7.1(0.0596) | ||
|
| (−)7.7(0.3368) | 7.7(0.416) | 0(0.3506) | ||
| ROS | CL-2070 | 18.5* | 14.9* | 25** | T-test |
| Thermo-tolerance | CL-2070 | 21.6*** | 18.2** | 21.5*** | T-test |
| Paralysis | CL-4176 | P<0.0004 | P<0.0002 | P<0.0164 | Log-rank test |
Figure 2Representative epifluorescence image of transgenic C. elegans (CL2070, hsp-16- 2/GFP) fed with or without herbs followed by a heat-shock treatment for 2 hr.
CL2070 (hsp-16-2/GFP) worms, grown at 20°C, were treated with vehicle control (Ctrl), SQDB (100 µg/ml), GS, CIN (10 µg/ml) for 48 h starting at 2 days of age. The worms were exposed to 35°C for 2 h and transferred to 20°C for 4 h to recover before fluorescence microscopy. Integrated Density means the sum of the values of the pixels in the image or selection. For quantifying a population of GFP reporter animals, each 40× image was analyzed using Image J software. Data are expressed as GFP integrated pixel density obtained from at least three independent experiments with at least 10 worms in each experimental group. **Statistically significant (independent t test, P<0.01); ***statistically significant, P<0.001.
Figure 3Intracellular levels of H2O2-related reactive oxygen species (ROS) in wild type C. elegans treated with SQDB, GS and CIN.
Age-synchronized C. elegans, maintained and collected as described in Materials and Methods, were assayed at day 4 of age after treatment with vehicle (control), herbal formula SQDB (100 µg/ml), CIN, GS (10 µg/ml) or L-ascorbic acid (Vit.C 10 µg/ml) for 48 h. The worms were then analyzed for H2O2 levels by incubation with 50 µM DCF-DA for 2.5 h, followed by measurement of fluorescent DCF production. Results are expressed as DCF fluorescence relative to untreated controls. *Statistically significant (independent t test, P<0.05); **statistically significant (P<0.01). Results are obtained from three independent experiments with a total of 300 worms.
Figure 4Paralysis assay in a transgenic C. elegans (CL4176) expressing Aβ.
Age synchronized CL4176 worms were treated from egg until the L3 larval stage with CIN, GS (10 µg/ml) and SQDB (100 µg/ml). The animals were allowed to cultivate at 16°C for 38 h. At the 38 h time point, the temperature was up-shifted to 23°C. Worms began to paralyze 25 h after the temperature up-shift and were scored at 1 hr intervals. Data are expressed as percent (%) of worms not paralyzed. SQDB, GS and CIN alleviate β amyloid-induced toxicity in the transgenic C. elegans strain.